Professional Documents
Culture Documents
Specific Aim
And why it is important?
In USA, the overall number of Emergency department visits increased from 120 millions to
137.8 millions from 2006-2014.
In 2006, there were 120.0 million ED visits in the United States. By 2014, there were 137.8
million ED visits, an increase of 14.8 percent. During that time period, the U.S. population grew
6.9 percent.10 The percentage of ED visits resulting in admission to the same hospital was
similar in 2006 and 2014 (15.4 and 14.1 percent, respectively).
Identify the facilities to be used (laboratory, clinical, animal, computer, office, other). If
appropriate, indicate their capacities, pertinent capabilities, relative proximity and extent of
availability to the project. Describe only those resources that are directly applicable to the
proposed work.
Provide any information describing the other resources available to the project (e.g., machine
shop, electronic shop) and the extent to which they would be available to the project.
Describe how the scientific environment in which the research will be done contributes to the
probability of success (e.g., institutional support, physical resources, and intellectual rapport). In
describing the scientific environment in which the work will be done, discuss ways in which the
proposed studies will benefit from unique features of the scientific environment or subject
populations or will employ useful collaborative arrangements.
For early stage investigators, describe institutional investment in the success of the investigator,
e.g., resources for classes, travel, training; collegial support such as career enrichment
programs, assistance and guidance in the supervision of trainees involved with the early stage
investigators’ project and availability of organized peer groups; logistical support, such as
administrative management and oversight and best practices training; and financial support,
such as protected time for research with salary support.
If there are multiple performance sites, describe the resources available at each site.
Describe any special facilities used for working with biohazards or other potentially dangerous
substances. Note: Information about select agents must be described in the Research Plan.
Biographical Sketch
The preliminary results section describes prior work by the investigators relevant to the
proposed project. Preliminary data can be essential part of a research grant application and
help to establish the likelihood of success of the proposed project.
For new applications—except for Exploratory/Development Grants (R21, R33), Small Research
Grants (R03), Academic Research Enhancement Award Grants (R15), and Phase I Small
Business Research Grants (R41/R43) —discuss the preliminary studies, data, and/or
experience pertinent to this application.
Early Stage Investigators should include preliminary data.
For renewing or revised applications, provide a progress report that—
Provides the beginning and ending dates for the period covered since the last competitive
review. Summarize the specific aims of the previous project period and the importance of the
findings, and emphasize the progress made toward their achievement.
Explains any significant changes to the specific aims and any new directions including changes
resulting from significant budget reductions.
Lists publications, manuscripts accepted for publication, patents, and other printed materials.
Enhanced review criteria are generally described below:
Overall Impact. Reviewers will provide an overall impact score to reflect their assessment of the
likelihood for the project to exert a sustained, powerful influence on the research field(s)
involved, in consideration of the following five core review criteria, and additional review criteria
(as applicable for the project proposed).
Core Review Criteria. Reviewers will consider each of the five review criteria below in the
determination of scientific and technical merit, and give a separate score for each. An
application does not need to be strong in all categories to be judged likely to have major
scientific impact. For example, a project that by its nature is not innovative may be essential to
advance a field.
Significance. Does the project address an important problem or a critical barrier to progress in
the field? If the aims of the project are achieved, how will scientific knowledge, technical
capability, and/or clinical practice be improved? How will successful completion of the aims
change the concepts, methods, technologies, treatments, services, or preventative interventions
that drive this field?
Investigator(s). Are the PD/PI, collaborators, and other researchers well suited to the project?
Do the investigators have appropriate experience and training? If the project is collaborative in
nature, do the investigators have complementary and integrated expertise? Are the leadership
approach, governance, and organizational structure appropriate for the project?
Innovation. Does the application challenge and seek to shift current research or clinical practice
paradigms by utilizing novel theoretical concepts, approaches or methodologies,
instrumentation, or interventions? Are the concepts, approaches or methodologies,
instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a
refinement, improvement, or new application of theoretical concepts, approaches or
methodologies, instrumentation, or interventions proposed?
Approach. Are the overall strategy, methodology, and analyses well-reasoned and appropriate
to accomplish the specific aims of the project? Are potential problems, alternative strategies,
and benchmarks for success presented? If the project is in the early stages of development, will
the strategy establish feasibility and will particularly risky aspects be managed?
If the project involves clinical research, are the plans for 1) protection of human subjects from
research risks, and 2) inclusion of minorities and members of both sexes/genders, as well as
the inclusion of children, justified in terms of the scientific goals and research strategy
proposed?
Environment. Will the scientific environment in which the work will be done contribute to the
probability of success? Are the institutional support, equipment and other physical resources
available to the investigators adequate for the project proposed? Will the project benefit from
unique features of the scientific environment, subject populations, or collaborative
arrangements?
Additional Review Criteria. As applicable for the project proposed, reviewers will consider the
following additional items in the determination of scientific and technical merit, but will not give
separate scores for these items and should not consider them in providing an overall impact
score.
Protections for Human Subjects. For research that involves human subjects but does not
involve one of the six categories of research that are exempt under 45 CFR Part 46, the
committee will evaluate the justification for involvement of human subjects and the proposed
protections from research risk relating to their participation according to the following five review
criteria: 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits to the
subjects and others, 4) importance of the knowledge to be gained, and 5) data and safety
monitoring, as appropriate, for the proposed research.
For research that involves human subjects and meets the criteria for one or more of the six
categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: 1)
the justification for the exemption, 2) human subjects involvement and characteristics, and 3)
sources of materials.
Budget and Period Support. Reviewers will consider whether the budget and the requested
period of support are fully justified and reasonable in relation to the proposed research.
Inclusion of Women and Minorities. Reviewers will evaluate the proposed plans for inclusion of
minorities and members of both genders.
Inclusion of Priority Populations. Reviewers will evaluate the proposed plans for inclusion of
AHRQ priority populations (see AHRQ policy notice at https://grants.nih.gov/grants/guide/notice-
files/NOT-HS-03-010.html for details).